Skip to main content
Top
Published in: BMC Gastroenterology 1/2023

Open Access 01-12-2023 | Colonoscopy | Research

High-dose polyethylene glycol-3350 and gatorade solutions for patients with previous inadequate bowel preparations for colonoscopy are safe and effective

Authors: David P. Gerard, Sophia F. Gerard, Manfred W. Raiser

Published in: BMC Gastroenterology | Issue 1/2023

Login to get access

Abstract

Background

Inadequate bowel preparation for colonoscopy remains an issue resulting in lower adenoma detection rates and increased cost. We assessed the efficacy, safety and tolerability of high-dose bowel preparations in subjects who previously had an inadequate colonoscopy preparation.

Methods

We performed a multi-step prospective trial of high-dose bowel preparations with subjects assigned to the dose higher than their previous inadequate preparation. Step 1: 1.5 times the standard-dose of polyethylene glycol 3350 (PEG, 459 g) and Gatorade; and Step 2: 2.0 times the standard-dose of PEG (612 g) and Gatorade, both were given as extended split-dose preparations. 69 outpatients consumed their preparation before a morning colonoscopy. The primary endpoint was colon cleanliness assessed by the Chicago bowel preparation scale (BPS). Safety was assessed by comparing a baseline basic metabolic panel (BMP) to a post-cleansing BMP. Patients with no history of inadequate colon cleansing who consumed standard doses of PEG (306 g to 357 g) and Gatorade were used as a comparison group. Tolerability of the bowel preparation was assessed using a subject-questionnaire.

Results

When compared to controls consuming standard-dose bowel preparations, subjects consuming high-dose preparations had no statistically significant difference in colon cleanliness as measured by the modified or total Chicago BPS scores or differences in tolerability. Baseline and post-cleaning BMPs were not significantly different other than the BUN falling (p < 0.0001) after the preparation.

Conclusions

The multi-step high-dose bowel cleansing protocol proved highly efficacious, safe and well tolerated in subjects who previously had an inadequate colonoscopy preparation.
Trial registration: ClinicalTrials.gov NCT02661750.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bucci C, Rotondano G, Hassan C, et al. Optimal bowel cleansing for colonoscopy: split the dose! A series of meta-analyses of controlled studies. Gastrointest Endosc 2014.pii:S0016-5107(14)01810-0. Bucci C, Rotondano G, Hassan C, et al. Optimal bowel cleansing for colonoscopy: split the dose! A series of meta-analyses of controlled studies. Gastrointest Endosc 2014.pii:S0016-5107(14)01810-0.
2.
go back to reference Kluge MA, Williams JL, Wu CK, et al. Inadequate Boston Bowel Preparation Scale scores predict the risk of missed neoplasia on the next colonoscopy. Gastrointest Endosc. 2018;87:744–51.CrossRefPubMed Kluge MA, Williams JL, Wu CK, et al. Inadequate Boston Bowel Preparation Scale scores predict the risk of missed neoplasia on the next colonoscopy. Gastrointest Endosc. 2018;87:744–51.CrossRefPubMed
3.
go back to reference ASGE Standards of Practice Committee, Saltzman JR, Cash BD, Pasha SF, et al. Bowel preparation before colonoscopy. Gastrointest Endosc. 2015;81:781–94 ASGE Standards of Practice Committee, Saltzman JR, Cash BD, Pasha SF, et al. Bowel preparation before colonoscopy. Gastrointest Endosc. 2015;81:781–94
4.
go back to reference Ben-Horin S, Bar-Meir S, Avidan B. The outcome of a second preparation for colonoscopy after preparation failure in the first procedure. Gastrointest Endosc. 2009;69(3 Pt 2):626–30.CrossRefPubMed Ben-Horin S, Bar-Meir S, Avidan B. The outcome of a second preparation for colonoscopy after preparation failure in the first procedure. Gastrointest Endosc. 2009;69(3 Pt 2):626–30.CrossRefPubMed
5.
go back to reference Ibáñez M, Parra-Blanco A, Zaballa P, et al. Usefulness of an intensive bowel cleansing strategy for repeat colonoscopy after preparation failure. Dis Colon Rectum. 2011;54:1578–84.CrossRefPubMed Ibáñez M, Parra-Blanco A, Zaballa P, et al. Usefulness of an intensive bowel cleansing strategy for repeat colonoscopy after preparation failure. Dis Colon Rectum. 2011;54:1578–84.CrossRefPubMed
6.
go back to reference Gimeno-García AZ, Hernandez G, Aldea A, et al. Comparison of two intensive bowel cleansing regimens in patients with previous poor bowel preparation: a randomized controlled study. Am J Gastroenterol. 2017;112:951–8.CrossRefPubMed Gimeno-García AZ, Hernandez G, Aldea A, et al. Comparison of two intensive bowel cleansing regimens in patients with previous poor bowel preparation: a randomized controlled study. Am J Gastroenterol. 2017;112:951–8.CrossRefPubMed
7.
go back to reference Fordtran JS, Hofmann AF. Seventy years of polyethylene glycols in gastroenterology: the journey of PEG 4000 and 3350 From nonabsorbable marker to colonoscopy preparation to osmotic laxative. Gastroenterology. 2017;152:675–80.CrossRefPubMed Fordtran JS, Hofmann AF. Seventy years of polyethylene glycols in gastroenterology: the journey of PEG 4000 and 3350 From nonabsorbable marker to colonoscopy preparation to osmotic laxative. Gastroenterology. 2017;152:675–80.CrossRefPubMed
8.
go back to reference Gerard DP, Foster DB, Holden JL, et al. Clinical trial of 1000 subjects randomized to 5 low-volume bowel preparations for colonoscopy and their acceptance of split-dose bowel preparations. J Clin Gastroenterol. 2017;51:512–21.CrossRefPubMed Gerard DP, Foster DB, Holden JL, et al. Clinical trial of 1000 subjects randomized to 5 low-volume bowel preparations for colonoscopy and their acceptance of split-dose bowel preparations. J Clin Gastroenterol. 2017;51:512–21.CrossRefPubMed
9.
go back to reference Gerard DP, Holden JL, Foster DB, et al. Randomized trial of Gatorade/polyethylene glycol with or without bisacodyl and NuLYTELY for colonoscopy preparation. Clin Transl Gastroenterol. 2012;3:1–9.CrossRef Gerard DP, Holden JL, Foster DB, et al. Randomized trial of Gatorade/polyethylene glycol with or without bisacodyl and NuLYTELY for colonoscopy preparation. Clin Transl Gastroenterol. 2012;3:1–9.CrossRef
10.
go back to reference Gerard DP, Foster DB, Raiser MW, et al. Validation of a new bowel preparation scale for measuring colon cleansing for colonoscopy: the Chicago Bowel Preparation scale. Clin Transl Gastroenterol. 2013;4:e43.CrossRefPubMedPubMedCentral Gerard DP, Foster DB, Raiser MW, et al. Validation of a new bowel preparation scale for measuring colon cleansing for colonoscopy: the Chicago Bowel Preparation scale. Clin Transl Gastroenterol. 2013;4:e43.CrossRefPubMedPubMedCentral
11.
go back to reference Lai EJ, Calderwood AH, Doros G, et al. The Boston Bowel Preparation scale: a valid and reliable instrument for colonoscopy oriented research. Gastrointest Endosc. 2009;69:620–5.CrossRefPubMedPubMedCentral Lai EJ, Calderwood AH, Doros G, et al. The Boston Bowel Preparation scale: a valid and reliable instrument for colonoscopy oriented research. Gastrointest Endosc. 2009;69:620–5.CrossRefPubMedPubMedCentral
12.
go back to reference Schiller LR, Emmett M, Santa Ana CA, et al. Osmotic effects of polyethylene glycol. Gastroenterology. 1988;94:933–41.CrossRefPubMed Schiller LR, Emmett M, Santa Ana CA, et al. Osmotic effects of polyethylene glycol. Gastroenterology. 1988;94:933–41.CrossRefPubMed
Metadata
Title
High-dose polyethylene glycol-3350 and gatorade solutions for patients with previous inadequate bowel preparations for colonoscopy are safe and effective
Authors
David P. Gerard
Sophia F. Gerard
Manfred W. Raiser
Publication date
01-12-2023
Publisher
BioMed Central
Keyword
Colonoscopy
Published in
BMC Gastroenterology / Issue 1/2023
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-023-02663-0

Other articles of this Issue 1/2023

BMC Gastroenterology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.